\n\nSubjects/Methods: ICFI was constructed using data from questionnaires on feeding practices and quantitative 24-h recalls (n = 1589). Multivariate analysis was used to control for household wealth and other confounding factors.\n\nResults: ICFI was positively correlated with complementary food energy intake (P < 0.0001) and MMDA (P < 0.0001). ICFI was associated with LAZ among 6-8 months children (P = 0.02). For all ages combined, there was a tendency towards an association that DNA Damage inhibitor did not reach statistical significance (P < 0.08).

Among feeding practices that formed ICFI, breastfeeding was associated with LAZ (P = 0.03) but not in the expected direction with +0.16 z-score difference in favour of non-breast-fed children. When breastfeeding was removed and introduced separately into the multivariate model, the relationship between the modified ICFI and LAZ became significant (P = 0.02).\n\nConclusions: Findings suggest that the ICFI could be a useful analytical tool, which needs however to be constructed according to its final use and which should be adapted to each context. European Journal of Clinical Nutrition (2009) 63, 718-724; doi:10.1038/ejcn.2008.10; published online 13 February 2008″
“Objective: Studies show that regular consumption of soybeans reduces the risk of diabetes and cardiovascular diseases. However, most of these studies recommend daily intake of 25 g or more of soy protein, an AZD3965 nmr amount considered high and not well tolerated

by patients. The objective of this study was to assess the effect of low daily intake of soybeans in oxidative stress and in components of the metabolic syndrome (MS). Subjects and methods: Forty individuals with MS were selected and divided into two groups: control group (n = 20) and soybean-treated group (n = 20), which consumed 12.95 g of soy protein for 90 days. Results: After the treatment, the soybean-treated group showed a decrease in fasting glucose and increase in serum HDL and adiponectin. Conclusion: Low intake of soy protein for 90 days, besides being well tolerated by the patients, was able to improve selleck products several parameters related to the pathophysiology

of MS. Arq Bras Endocrinol Metab. 2011;55(6):399-405″
“Objective. To develop, implement, and evaluate a targeted educational intervention focusing on smoking cessation with final-year undergraduate pharmacy students.\n\nDesign. A smoking-cessation educational workshop entitled Smoking Cessation in Pharmacy (SCIP) was designed on the principles of adult learning and implemented with a full cohort of final-year undergraduate pharmacy students at the University of Sydney. A previously validated questionnaire testing the knowledge and attitudes of respondents was administered both before and after implementation of the designed workshop to evaluate changes resulting from the intervention. Informal feedback was obtained from students.\n\nAssessment. Pre-course mean total knowledge and attitude scores calculated were 65.8+/-9.